======= SMCHD1 ======= == Gene Information == * **Official Symbol**: SMCHD1 * **Official Name**: structural maintenance of chromosomes flexible hinge domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23347|23347]] * **UniProt**: [[https://www.uniprot.org/uniprot/A6NHR9|A6NHR9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SMCHD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMCHD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614982|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: Required for maintenance of X inactivation in females and hypermethylation of CpG islands associated with inactive X. Involved in a pathway that mediates the methylation of a subset of CpG islands slowly and requires the methyltransferase DNMT3B (By similarity). Required for DUX4 silencing in somatic cells (PubMed:23143600). {ECO:0000250|UniProtKB:Q6P5D8, ECO:0000269|PubMed:23143600}. |SMC hinge| |inactivation of X chromosome by heterochromatin assembly| |inactivation of X chromosome by DNA methylation| |heterochromatin organization involved in chromatin silencing| |Barr body| |heterochromatin assembly| |positive regulation of double-strand break repair via nonhomologous end joining| |nose development| |dosage compensation by inactivation of X chromosome| |heterochromatin organization| |dosage compensation| |negative regulation of double-strand break repair via homologous recombination| |regulation of double-strand break repair via nonhomologous end joining| |negative regulation of double-strand break repair| |positive regulation of double-strand break repair| |negative regulation of DNA repair| |negative regulation of DNA recombination| |regulation of double-strand break repair via homologous recombination| |site of double-strand break| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |positive regulation of DNA repair| |chromatin organization involved in regulation of transcription| |regulation of double-strand break repair| |negative regulation of response to DNA damage stimulus| |negative regulation of gene expression, epigenetic| |positive regulation of response to DNA damage stimulus| |regulation of DNA recombination| |nuclear chromosome, telomeric region| |negative regulation of DNA metabolic process| |regulation of DNA repair| |chromatin assembly| |gene silencing| |chromatin assembly or disassembly| |chromatin remodeling| |DNA packaging| |double-strand break repair| |positive regulation of DNA metabolic process| |respiratory system development| |regulation of response to DNA damage stimulus| |ATPase activity| |regulation of gene expression, epigenetic| |DNA conformation change| |regulation of DNA metabolic process| |DNA repair| |sensory organ development| |chromatin organization| |regulation of cellular response to stress| |DNA metabolic process| |cellular response to DNA damage stimulus| |protein homodimerization activity| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |ATP binding| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of response to stimulus| |cellular response to stress| |negative regulation of gene expression| |positive regulation of nucleobase-containing compound metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp360|Genistein 15μM R07 exp360]]|-2.26| |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-2.11| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-2.09| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.98| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.72| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 5/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12183 * **Expression level (log2 read counts)**: 8.02 {{:chemogenomics:nalm6 dist.png?nolink |}}